AMN
protein-codingamnion associated transmembrane protein
Gene summary
The protein encoded by this gene is a type I transmembrane protein. It is thought to modulate bone morphogenetic protein (BMP) receptor function by serving as an accessory or coreceptor, and thus facilitates or hinders BMP binding. It is known that the mouse AMN gene is expressed in the extraembryonic visceral endoderm layer during gastrulation, but it is found to be mutated in amnionless mouse. The encoded protein has sequence similarity to short gastrulation (Sog) and procollagen IIA proteins in Drosophila. [provided by RefSeq, Jul 2008]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~10.9 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0009853
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0100157
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0100157
Submitter: Natera
Inheritance Pattern: AR
Disease ID:MONDO:0100156
Submitter: Labcorp Genetics (formerly Invitae)
Clinical Genomic Database (CGD)
Manifestation: Gastrointestinal; Hematologic; Renal
Intervention: Gastrointestinal
Rationale: Early diagnosis is beneficial, as early detection may allow life-long medical treatment with parenteral hydroxocobalamin, which can ameliorate morbidity and mortality
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to AMN variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_030943.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 5 | 217 | 222 | |||
| missense | 1 | 3 | 155 | 12 | 171 | |
| nonsense | 9 | 4 | 13 | |||
| start loss | 0 | |||||
| frameshift | 18 | 18 | 4 | 40 | ||
| splice donor/acceptor (+/-2bp) | 2 | 18 | 20 | |||
| Total | 30 | 43 | 164 | 229 | 0 | 466 |
Highest pathogenic variant AF is 0.000074668525
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_112205.2 | 12 | MANE Select | |
| Ensembl | ENSP00000299155.6 | 12 | MANE Select | |
| RefSeq | NP_001412175.1 | 10 | Standard | |
| Ensembl | ENSP00000453786.1 | 3 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- HDL clearance
- Cobalamin (Cbl, vitamin B12) transport and metabolism
- Metabolism
- Plasma lipoprotein clearance
- Transport of small molecules
Biological Process
- receptor-mediated endocytosis
- multicellular organism development
- excretion
- cobalamin metabolic process
- cobalamin transport
Molecular Function
- signaling receptor binding
Cellular Component
- extracellular space
- plasma membrane
- clathrin-coated pit
- endosome membrane
- integral component of membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000299155
- Coding exons
- 12
- Length
- 10941
- Individuals with no LoFs
- 125471
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 37
- Defined
- 125508
- p
- 0.000147
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.606 | 230 | 257 | 0.894 | 0.0000126 | 2784 |
| Missense (PolyPhen) | 65 | 66.067 | 0.98385 | 775 | ||
| Synonymous | -0.756 | 134 | 123 | 1.09 | 0.00000652 | 1017 |
| Loss of Function | 2.17 | 9 | 19.3 | 0.467 | 8.29e-7 | 215 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.000064 | 0.000062 | rare |
| Latino/Admixed American | 0.000029 | 0.000029 | rare |
| Ashkenazi Jewish | 0.00010 | 0.000099 | rare |
| East Asian | 0.00011 | 0.00011 | rare |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.00020 | 0.00018 | rare |
| South Asian | 0.00036 | 0.00036 | rare |
| Other | 0.00016 | 0.00016 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Necessary for efficient absorption of vitamin B12 (PubMed:12590260, PubMed:14576052). Required for normal CUBN- mediated protein transport in the kidney. May direct the production of trunk mesoderm during development by modulating a bone morphogenetic protein (BMP) signaling pathway in the underlying visceral endoderm (By similarity). {ECO:0000250|UniProtKB:Q99JB7, ECO:0000269|PubMed:14576052, ECO:0000305|PubMed:12590260}.;
- Disease
- DISEASE: Recessive hereditary megaloblastic anemia 1 (RH-MGA1) [MIM:261100]: Due to selective malabsorption of vitamin B12. Defects in vitamin B12 absorption lead to impaired function of thymidine synthase. As a consequence DNA synthesis is interrupted. Rapidly dividing cells involved in erythropoiesis are particularly affected. {ECO:0000269|PubMed:12590260, ECO:0000269|PubMed:22631584}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.208
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |